HDFC Pharma and Healthcare Fund vs WhiteOak Capital Consumption Opportunities Fund
Direct Plan, Growth option · Data as on 30-10-2026
HDFC Pharma and Healthcare Fund is a Thematic fund and WhiteOak Capital Consumption Opportunities Fund is a Thematic fund. HDFC Pharma and Healthcare Fund charges 1.05% a year and WhiteOak Capital Consumption Opportunities Fund 1.09% (Direct plans). Their portfolios overlap 6.3%: they hold 4 of the same securities.
HDFC Pharma and Healthcare Fund
Thematic
- Expense ratio
- 1.05%
- NAV
- ₹21.95
WhiteOak Capital Consumption Opportunities Fund
Thematic
- Expense ratio
- 1.09%
- NAV
- ₹9.88
Which is better, HDFC Pharma and Healthcare or WhiteOak Capital Consumption Opportunities? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- HDFC Pharma and Healthcare costs less: 1.05% a year against 1.09% (Direct plans).
- HDFC Pharma and Healthcare fell less in its worst fall since 11-02-2026: −9.8% against −13.7%.
- WhiteOak Capital Consumption Opportunities holds more in large companies: 46.0% of the fund in large caps against 29.2%.
- HDFC Pharma and Healthcare is the larger fund: ₹3,501 Cr against ₹135 Cr.
- Their portfolios overlap 6.3%: 4 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | HDFC Pharma and Healthcare Fund | WhiteOak Capital Consumption Opportunities Fund |
|---|---|---|
| Fund house | HDFC Mutual Fund | WhiteOak Capital Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹3,501 Cr (30-09-2026) | ₹135 Cr (30-09-2026) |
| NAV | ₹21.95 (Direct) | ₹9.88 (Direct) |
| Expense ratio (Direct) | 1.05% | 1.09% |
| Expense ratio (Regular) | 2.13% | 2.73% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty India Consumption TRI |
| Launch date | 04-10-2023 | 10-02-2026 |
| Minimum investment | ₹100 | ₹100 |
| Lock in | None | None |
| Fund managers | Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar | Ramesh Mantri, Piyush Baranwal, Trupti Agrawal, Dheeresh Pathak, Ashish Agrawal |
| Exit load | In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment. | Nil |
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | +0.04% | +0.83% | +16.68% | +23.12% | +30.53% | -- | -- |
| WhiteOak Capital Consumption Opportunities Fund (Direct) | −1.44% | −5.12% | +3.02% | -- | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | -- | -- | -- | -- |
Category average: the average of the 235 Thematic funds, same plan type.
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Year-wise Returns
| Year | HDFC Pharma and HealthcareHDFC Pharma and Healthcare | WhiteOak Capital Consumption OpportunitiesWhiteOak Capital Consumption Opportunities |
|---|---|---|
| 2026to date | +23.99% | -- |
| 2025 | +2.42% | -- |
| 2024 | +52.22% | -- |
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | HDFC Pharma and Healthcare Fund (Direct) | WhiteOak Capital Consumption Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +29.32% | −1.84% |
| Standard deviation | 13.98% | 14.84% |
| Sharpe ratio | 1.66 | -0.48 |
| Sortino ratio | 2.38 | -0.64 |
| Maximum drawdown | −14.9% (28-02-2025) | −13.7% (23-03-2026) |
| Beta | 0.95 | 0.85 |
| Alpha | +8.51% | +5.65% |
From daily NAVs, 04-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
HDFC Pharma and Healthcare Fund (Direct)
WhiteOak Capital Consumption Opportunities Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund (Direct) | −9.8% | 21-09-2026 | 23-10-2026 | Not yet | -- | −4.1% |
| WhiteOak Capital Consumption Opportunities Fund (Direct) | −13.7% | 11-02-2026 | 23-03-2026 | 30-06-2026 | 3 months | −7.3% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 11-02-2026, the first day every fund has.
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Portfolio Overlap
From each fund's latest monthly portfolio: HDFC Pharma and Healthcare Fund, September 2026; WhiteOak Capital Consumption Opportunities Fund, September 2026
Holdings in common
- Overlap
- 6.3%
- Held by both
- 4
- Only in HDFC Pharma and Healthcare
- 34
- Only in WhiteOak Capital Consumption Opportunities
- 46
| Security | % of HDFC Pharma and Healthcare | % of WhiteOak Capital Consumption Opportunities |
|---|---|---|
| Max Healthcare Institute Limited | 3.61% | 2.25% |
| Torrent Pharmaceuticals Ltd. | 3.65% | 1.73% |
| Krishna Institute Of Medical Sciences Limited | 2.10% | 1.31% |
| CORONA REMEDIES LIMITED | 1.04% | 1.52% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 6.3% means 6.3% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in HDFC Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Divis Laboratories Ltd. | 9.39% |
| Sun Pharmaceutical Industries Ltd. | 8.28% |
| Alkem Laboratories Ltd. | 4.64% |
| Cipla Ltd. | 4.15% |
| Apollo Hospitals Enterprise Ltd. | 3.69% |
Largest holdings only in WhiteOak Capital Consumption Opportunities Fund
| Security | % of fund |
|---|---|
| Bharti Airtel Limited | 7.76% |
| Nestle India Limited | 7.60% |
| Eternal Limited | 7.52% |
| Mahindra & Mahindra Limited | 6.40% |
| Titan Company Limited | 4.89% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | HDFC Pharma and Healthcare | WhiteOak Capital Consumption Opportunities |
|---|---|---|
| Equity | 96.8% | 90.0% |
| Debt | 0.0% | 2.6% |
| Cash and others | 3.2% | 7.4% |
Market cap of stocks
| Market cap | HDFC Pharma and Healthcare | WhiteOak Capital Consumption Opportunities |
|---|---|---|
| Large Cap | 29.2% | 46.0% |
| Mid Cap | 30.1% | 12.9% |
| Small Cap | 32.5% | 29.8% |
| Not on AMFI's list | 5.0% | 1.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | HDFC Pharma and Healthcare | WhiteOak Capital Consumption Opportunities |
|---|---|---|
| Pharmaceuticals & Biotechnology | 71.3% | 3.3% |
| Healthcare Services | 22.1% | 3.6% |
| Retailing | 1.0% | 18.9% |
| Consumer Durables | 0.0% | 15.9% |
| Food Products | 0.0% | 10.3% |
| Automobiles | 0.0% | 9.8% |
| Telecom - Services | 0.0% | 7.8% |
| Agricultural Food & other Products | 0.0% | 4.6% |
| Healthcare Equipment & Supplies | 2.4% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
HDFC Pharma and Healthcare vs WhiteOak Capital Consumption Opportunities: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | HDFC Pharma and Healthcare Fund | WhiteOak Capital Consumption Opportunities Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.05% | 1.09% |
| Base expense ratio (Direct) | 0.71% | 0.71% |
| Total expense ratio (Regular) | 2.13% | 2.73% |
| Base expense ratio (Regular) | 1.65% | 2.10% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare HDFC Pharma and Healthcare with
Compare WhiteOak Capital Consumption Opportunities with
HDFC Pharma and Healthcare Fund vs WhiteOak Capital Consumption Opportunities Fund: Frequently Asked Questions
What is the difference between HDFC Pharma and Healthcare Fund and WhiteOak Capital Consumption Opportunities Fund?
HDFC Pharma and Healthcare Fund is a Thematic fund, WhiteOak Capital Consumption Opportunities Fund is a Thematic fund, run by HDFC Mutual Fund and WhiteOak Capital Mutual Fund. Their portfolios overlap 6.3%. HDFC Pharma and Healthcare Fund charges 1.05% a year and WhiteOak Capital Consumption Opportunities Fund 1.09%.
Which has the lower expense ratio, HDFC Pharma and Healthcare Fund or WhiteOak Capital Consumption Opportunities Fund?
HDFC Pharma and Healthcare Fund charges less: 1.05% a year against 1.09%. These are the Direct plans' total expense ratios reported to AMFI.
How much do HDFC Pharma and Healthcare Fund and WhiteOak Capital Consumption Opportunities Fund overlap?
6.3%. They hold 4 of the same securities, the largest shared ones being MAXHEALTH, TORNTPHARM, KIMS. From each fund's latest monthly portfolio.
Which is riskier, HDFC Pharma and Healthcare Fund or WhiteOak Capital Consumption Opportunities Fund?
On SEBI's riskometer, HDFC Pharma and Healthcare Fund is rated Very High and WhiteOak Capital Consumption Opportunities Fund Very High. Over their common history, the standard deviation of daily returns was 13.98% and 14.84% a year.
Can I invest in both HDFC Pharma and Healthcare Fund and WhiteOak Capital Consumption Opportunities Fund?
Yes. 6.3% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Who manages HDFC Pharma and Healthcare Fund and WhiteOak Capital Consumption Opportunities Fund?
HDFC Pharma and Healthcare Fund: Nikhil Mathur, Gopal Agrawal, Bhagyesh Kagalkar. WhiteOak Capital Consumption Opportunities Fund: Ramesh Mantri, Piyush Baranwal, Trupti Agrawal, Dheeresh Pathak, Ashish Agrawal.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.